Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 96 for “"Chagas"”.
-
Factors Affecting the Epidemiology of Chagas' Disease
Made available in DSpace on 2014-12-09T22:30:06Z (GMT). No. of bitstreams: 1 6507151.pdf: 7185978 bytes, checksum: ce02f0aad3fbd6401e2d135e8b1affcf (MD5) Previous issue date: 1965
-
Efficacy and Safety of Pharmacological Treatments of Chagas Disease
Background: Chagas disease is a neglected tropical disease that causes a high burden of disease in the Americas. Current trypanocidal treatments vary drastically in efficacy, depending on the stage of disease and the drugs administered. Conventional trypanocidals present a significant risk of …
-
The eco-epidemiology of Chagas disease risk in Panama
Chagas disease is a vector-borne disease affecting between 5 to10 million people world-wide. It is spread by dozens of species of blood-feeding triatomines (Hemiptera: Reduviidae). Trypanosoma cruzi, a kinetoplastid protozoan parasite and causative agent of Chagas disease, is shed in the feces of …
-
Crescimento da literatura brasileira de doença de Chagas: análise bibliométrica
Historical outline of Chagas' disease, since its discovery by Carlos Chagas up to currently research areas, in Brazil. Goffman's theory on the works on Chagas' disease and the use of the deterministic model, verifying a growth of the literature after 1933.
-
The Beneficial Effect of Vitamin E and Selenium During Experimental Chagas' Disease
… positive synergistic effect during experimental Chagas' disease. In the first phase of the study, 25 female C3HeB/FeJ mice were infected with a Brazil strain of Trypanosoma cruzi while receiving vitamin E supplementation of 0 IU/kg, 200 IU/kg, 400 IU/kg, 600 IU/kg, 800 IU/kg in their diets. In …
-
SIRT1 ACTIVATION IMPROVES HEART FUNCTION THROUGH INHIBITION OF INFLAMMATION IN CHAGAS DISEASE
Chronic chagasic cardiomyopathy (CCM) is presented by increased oxidative/inflammatory stress and decreased mitochondrial bioenergetics. SIRT1 senses the redox changes and integrates mitochondrial metabolism and inflammation; and SIRT1 deficiency may be a major determinant in CCM. To test this, …
-
Avaliação soroepidemiológica da Doença de Chagas no município de Santo André-PB
Chagas disease (CD) is an infectious disease caused by Trypanosoma cruzi parasite and is a serious public health problem. It is a neglected disease may be asymptomatic or have cardiac and / or digestive complications. Therefore this study aims to carry out a seroepidemiological assessment of Chagas …
-
The Effect of Dietary Supplemented Vitamin E and Selenium on Experimental Chagas' Disease
… of Trypanosoma cruzi, the causative agent of Chagas' disease. To study the role of diet on the course of experimental Chagas' disease, C3HeB/FeJ mice were fed pelleted, synthetic food containing no vitamin E and selenium, 800 IU/kg vitamin E, 2 ppm selenium, or food containing 800 IU/kg …
-
Eco-epidemiología, evolución y filogenética de la tribu Rhodniini: Vectores dela enfermedad de Chagas
… cruzi, responsable de la enfermedad de Chagas, la cual es de gran impacto en países de Latinoamérica. Existen diferentes mecanismos de transmisión de la enfermedad, entre ellos se encuentran: la transmisión vectorial, transfusional, congénita, mediante trasplante de órganos, accidental …
-
Evaluación del rendimiento diagnóstico de técnicas ELISA para la Enfermedad de Chagas en Colombia
Introducción: La enfermedad de Chagas es producida por el Trypanosoma cruzi, endémica en América Latina. El diagnóstico es complejo, lo cual constituye una barrera al acceso actualmente. El método recomendado por la OMS en fase crónica es una combinación de dos pruebas inmunoserológicas con …
-
Reactivación de enfermedad de Chagas en pacientes trasplantados por cardiopatía chagásica. Fundación Cardioinfantil 2020.
La enfermedad de Chagas es una enfermedad endémica de América Latina con una creciente incidencia en otros países como Estados Unidos, dado el aumento de migrantes desde zonas endémicas. El compromiso cardiaco por enfermedad de Chagas se presenta entre el 20-30% de los pacientes a largo plazo y …
-
Congenital Chagas Murine Model Development and Nanovaccine Efficacy Against Maternal-fetal Trypanosoma cruzi Pathogenesis
… from mother to fetus known as congenital Chagas’ disease (cCD). The objective was to develop a murine model of cCD to test the efficacy of a DNA nanovaccine developed by our laboratory. In this dissertation, we demonstrate that Tc infection in female mice delayed the initiation of …
-
Chagas disease, need and progress made in implementing donor blood screening in the United States.
Background: Chagas disease is a parasitic infection caused by Trypanosoma cruzi affecting 11 million people worldwide. The condition can be acquired via exposure of a wound or mucosa to infected feces from a reduviid bug, blood transfusion or congenitally. It is estimated that there are between …
-
Estudo de degradação do fármaco benznidazol utilizado no combate a doença de chagas por hidrólise, oxidação, fotólise e termodegradação
… de escolha para o tratamento da doença de Chagas, doença crônica que leva o paciente à utilização da medicação com o BNZ por longos períodos de tempo. A ingestão prolongada deste fármaco pode levar ao seu acúmulo no organismo, podendo esse sofrer uma série de reações inesperadas em …
-
Chagas Disease in the United States: the Emerging Threat and the Role Climate and Awareness Play in Its Spread
… and disease awareness in the emergence of Chagas disease (American trypanosomiasis). Chagas disease is endemic in Latin America and primarily spreads to humans directly via the triatomine vector. Hosts for most triatomine species are mainly rodents and occasionally dogs. The disease itself …
-
A influencia da cepa e da reinfecçãoTrypanosom a cruzi para o tabelecimento da forma crônica sintomática da doença de Chagas
… DA FORMA CRÔNICA SINTOMÁTICA DA DOENÇA DE CHAGAS A doença de Chagas ainda se mostra, na América Latina, como um preocupante problema de saúde pública. Tendo como causador da infecção o protozoário Trypanosoma cruzi, que é transmitido ao homem por insetos hematófagos, pertencentes aos …
-
Uso de CDI em pacientes com cardiomiopatia chagásica: revisão sistemática
Introdução: A fase crônica da doença de Chagas é uma das patologias de mais larga distribuição no continente americano. Dentre as causas de morte identificadas nesses pacientes a morte súbita aparece como uma das principais, estimando-se ser responsável por cerca de 55 a 65% dos óbitos. Nesse …
-
Análisis comparativo de la frecuencia y perfil epidemiológico en pacientes con resultado reactivo para Chagas en los servicios de infectología y cardiología del Hospital Nacional Rosales, de enero a junio 2025
La enfermedad de Chagas representa un desafío epidemiológico significativo en El Salvador. El análisis comparativo de resultados serológicos entre servicios especializados permite identificar patrones diferenciales que orientan estrategias de vigilancia. Se analizó comparativamente la frecuencia y …
Page 1 of 5